Member Hub
A central workspace for Access360 briefings, archive navigation, member Q&A, annual system-wide outlooks, and NRDL+ Masterclass materials.
Latest Briefings
China’s 2026 Dual-List Draft Workplan: Earlier Innovation Access, Tighter Lifecycle Pricing Discipline
China’s 2026 NRDL draft workplan signals a more integrated, lifecycle-oriented reimbursement framework: earlier access for innovative therapies, closer regulatory–reimbursement alignment anchored in RWE, and tighter pricing discipline for mature and me-too products.
China’s Healthcare System Is Reorganizing: What It Means for Manufacturers
As China’s healthcare system reorganizes, evolving care pathways and payment dynamics are reshaping how access is secured and how value is realized.
RWE and the Quiet Rewiring of China’s Reimbursement System
Five recent policy releases show how real-world evidence is quietly reshaping pricing, reimbursement, and clinical adoption for both innovative and established medicines in China.
Three Shifts Reshaping China’s Drug Payment System: Implications for Global Pharma
China’s drug payment system is shifting from isolated policy levers toward an environment defined by their interaction. Recent signals are beginning to link pricing, launch timing, and multi-payer access in ways that materially change how global pharma approaches China.
From Reference Tool to Operating Model: A Roadmap for China’s C-List
China’s C-List establishes a national reference for innovative drugs outside the NRDL—but not yet a payment system. Its impact will hinge on whether insurers and regulators can turn policy intent into a workable, risk-sustainable commercial coverage model.
Explore the Archive
Access the full Access360 archive organized by strategic theme, including coverage and funding pathways, pricing and procurement governance, provider payment reform, commercial health insurance and C-List dynamics, and broader system-level analyses.
Submit Access360 Member Questions
Access360 members are welcome to submit questions related to published briefings. Each month, written responses are organized around main themes and shared with members.
Members may also suggest future briefing topics to help ensure Access360 continues to address issues most relevant to their work and decision needs.
Annual System-Wide Outlook
A flagship live annual Access360 member briefing examining major developments shaping China’s health policy, pricing, coverage, financing, and adoption environment for medical technologies, with forward-looking implications for life sciences companies. Each named Access360 member may invite one guest, subject to registration approval and capacity limits.
NRDL+ Masterclass
Access pre-read materials, recorded briefings, live case discussions, and question submission forms for NRDL+ Masterclass programs.
Available to registered Masterclass participants.
Named Access360 members are eligible for a 20% Masterclass discount. Group enrollment discounts are available upon request.
Not yet a member?
Access360 membership is available for individual professionals and enterprise teams seeking ongoing China access intelligence.